Related Experiment Video
Updated: Aug 7, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
[Interaction of the antineoplastic agent mitoxantrone with double-stranded nucleic acids]
Mitoxantrone binds to double-helical DNA and RNA through intercalation and electrostatic interactions. Binding affinity depends on GC-content, with stoichiometry varying between DNA and RNA.
Area of Science:
- Biochemistry
- Molecular Biology
- Biophysics
Context:
- Mitoxantrone is an anticancer agent.
- Understanding drug-nucleic acid interactions is crucial for drug development.
- Previous studies have suggested intercalation as the primary binding mode.
Purpose:
- To investigate the binding mechanism of mitoxantrone with double-helical DNA and RNA.
- To quantify binding stoichiometry and affinity under varying ionic strengths and temperatures.
- To elucidate the contributions of intercalation and electrostatic interactions to binding.
Summary:
- Mitoxantrone binds to double-helical DNA and RNA via intercalation and electrostatic interactions of its side chains.
- Binding stoichiometry is approximately 1:2-3 base pairs for DNA and 1:6-8 base pairs for RNA at 0.11 M NaCl.
- Binding enthalpy is approximately -(3.0 ± 0.5) kcal/mol, with affinity dependent on GC-content.
Impact:
- Provides detailed insights into mitoxantrone-nucleic acid interactions.
- Informs the design of novel anticancer agents with improved efficacy and reduced side effects.
- Contributes to the understanding of drug binding mechanisms to genetic material.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
07:58An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations
Antiviral Nucleoside Inhibitors